ADMA Biologics, Inc. (ADMA)

16.54 +0.16 (+0.98%) USD  |  NASDAQ  |  Mar 04, 16:00
16.78 +0.24 (+1.45%) Pre-Market: 08:10
More

ADMA Biologics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
AtriCure, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade